Related Experiment Video
Updated: Dec 22, 2025
11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
7.9K
MicroRNA-597 inhibits NSCLC progression through negatively regulating CDK2 expression
1Department of Respiration, China Japan Union Hospital of Jilin University, Changchun, China. zhongmingyn@163.com.
Summary
MicroRNA-597 is downregulated in non-small cell lung cancer (NSCLC), correlating with poorer prognosis. This microRNA suppresses NSCLC progression by targeting CDK2, offering potential therapeutic insights.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNA-597 is recognized as a tumor suppressor.
- Its specific role in non-small cell lung cancer (NSCLC) requires further investigation.
Purpose of the Study:
- To investigate microRNA-597 expression in NSCLC.
- To explore the underlying molecular mechanisms of microRNA-597 in NSCLC progression.
Main Methods:
- Real-time quantitative polymerase chain reaction (qPCR) for microRNA-597 and CDK2 expression analysis in NSCLC tissues and cell lines.
- Construction of microRNA-597 overexpression and knockdown models.
- Cell proliferation assays (CCK-8, colony formation, EdU).
- Luciferase reporter gene assay and recovery experiments to validate target interaction.
Main Results:
- MicroRNA-597 expression was significantly lower in NSCLC tissues and cell lines compared to normal controls.
- Low microRNA-597 expression correlated with advanced pathological stage and poorer overall survival in NSCLC patients.
- MicroRNA-597 overexpression inhibited NSCLC cell proliferation, while knockdown promoted it.
- MicroRNA-597 directly targets and downregulates CDK2, and CDK2 can reverse the suppressive effects of microRNA-597 on NSCLC progression.
Conclusions:
- MicroRNA-597 is significantly downregulated in NSCLC and is associated with poor prognosis.
- MicroRNA-597 suppresses NSCLC malignant progression by targeting CDK2.
- MicroRNA-597 represents a potential therapeutic target for NSCLC.
More Related Videos
09:45An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
8.8K
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.4K
Related Concept Videos
01:22MicroRNAs
3.6K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
01:22MicroRNAs
23.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.7K
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
01:23Negative Regulator Molecules
38.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.1K
02:23Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
03:03mTOR Signaling and Cancer Progression
4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.5K